Approval · Notice of Compliance 1003 · 2000
SENSORCAINE FORTE: Notice of Compliance 1003
Issued March 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1003
- Date
- March 24, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Local anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE FORTE | 01976214 | Cancelled Post Market |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML
- EPINEPHRINE BITARTRATE 5 MCG per ML